Workit Health’s blend of technology, clinical care, and community improves outcomes while removing barriers, resulting in lasting recovery from opioid and alcohol use disorders.

Our program includes:

• Telehealth medication for opioid and alcohol use disorder
• Support for over 30 co-occurring disorders
• Measurement-based care and screening
• Automated drug testing focused on convenience and compliance
• 60+ mutual support and counselor-led virtual groups
• Medication delivery available in select states

Founded in 2015 by two women in recovery, Workit Health has been addressing substance use disorders using a virtual-first model for eight years, and has provided care for over 23,000 members.

Workit Health expands access to evidence-based, person-centered treatment for people struggling with drugs and alcohol, with appointments available within 48 hours.

Founded in 2015 by two women in recovery, Workit Health has been addressing substance use disorders using a virtual-first model for eight years and has provided care for over 23,000 members. The Workit program includes video visits with licensed clinicians, e-prescribing for substance use disorders and comorbid conditions, and psychosocial, therapeutic support. Workit’s innovative technology removes barriers and expands access to evidence-based, person-centered treatment for people struggling with drugs and alcohol, improving outcomes while reducing costs.

Bloomlife combines connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. Through our connected care platform we are aggregating first of its kind longitudinal data for digital biomarker discovery to improve risk stratification.  

Bloomlife is a clinical stage women’s health company developing remote prenatal care solutions for the 20% of high risk pregnancies that drive 60% of the $110B annual US healthcare spend. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events Bloomlife aims to ensure every family gets a healthy start.

Bloomlife has been recognized for its revolutionary vision and potential to impact lives globally, most recently receiving innovation awards and grants from Johnson & Johnson, Fast Company World Changing Ideas, Maternal and Child Health Bureau, National Science Foundation, and the European Commission Horizon 2020 Initiative.

• Workit Health's harm-reduction focus, human-centered design, and clinical rigor elevate us above our competitors. We offer more comprehensive treatment options than other companies in our space, treating opioid, alcohol, and stimulant use disorders, and offering therapeutic support for other process and behavioral addictions. 
• Over six years ago, Workit Health pioneered virtual drug screens for our members. We began with a system of video connection, allowing a staff member to verify a drug test via telemedicine, and in 2022 we launched the Automated Drug Testing system. It is the first of its kind in digital health, and a patent is pending. Automated Drug Testing empowers Workit members to take control of their own recovery, while also allowing members the flexibility to complete urine drug screens at any time of day or night, anywhere they have privacy and wifi. 
• In 2022, we expanded our services to cover conditions that are commonly comorbid with substance use disorder, including hepatitis C, anxiety, depression, insomnia, and PrEP for HIV. We also began offering the first telehealth treatment program for stimulant use disorder, incorporating clinical care and contingency management along with behavioral health support.

Current antepartum fetal monitoring requires weekly trips to the clinic which is time consuming and inconvenient. For women in underserved communities difficulty accessing care can lead to poor adherence to screening guidelines.

By shifting antepartum fetal monitoring to the home, Bloomlife saves patients time and money, increases adherence to screening guidelines, and frees up valuable clinical resources.

Unlike the competition, Bloomlife does not require messy gels making the product experience more convenient for patients.